Apnimed, Inc.

NASDAQ:APMD

Biotechnology

Healthcare
$17.45 +2.84%

+$0.71 today

Market cap
$726.46M
Beta
0.00

Volume 0.30M

Average 1.15M

APMD Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

No reported Net Receivables figures are available to summarize.

Net Receivables history

Currency unavailable · from the balance sheet

No Net Receivables data reported for this period type.

Net Receivables vs competitors

How APMD compares with its peers on the latest reported figures

APMD Competitors
Net Receivables for APMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INSPInspire Medical Systems, Inc.Jun 2026$103.34M USD-24.9%+25.0%11.2%
NYXHNyxoah S.A.Mar 2026€9.25M EUR+61.3%+51.3%9.4%
APMDApnimed, Inc.—— ———
Peer median (excluding APMD) —+18.2%+38.1%10.3%

Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Apnimed, Inc.

NASDAQ:APMD

Intrinsic Alpha fair value

Locked

Current Price

$17.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.